Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
1147 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Component of inhibitor of nuclear factor kappa B kinase complex |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
CHUK |
SynonymsGene synonyms aliases
|
BPS2, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 |
ChromosomeChromosome number
|
10 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
10q24.31 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs267606736 |
G>A |
Pathogenic |
Coding sequence variant, stop gained, non coding transcript variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
Transcription factor |
Regulation |
Reference |
ETS1 |
Activation |
15469934 |
TP53 |
Repression |
15469934 |
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0002223 |
Process |
Stimulatory C-type lectin receptor signaling pathway |
TAS |
|
GO:0002479 |
Process |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
TAS |
|
GO:0002756 |
Process |
MyD88-independent toll-like receptor signaling pathway |
TAS |
|
GO:0003009 |
Process |
Skeletal muscle contraction |
IEA |
|
GO:0004672 |
Function |
Protein kinase activity |
IDA |
20434986 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
IBA |
21873635 |
GO:0005515 |
Function |
Protein binding |
IPI |
8246997, 9520446, 9751060, 10521409, 10733566, 11297557, 11971985, 12482991, 12486103, 12730857, 14743216, 15125834, 15601829, 15749833, 16126728, 16129692, 16286467, 16319058, 16498412, 16938294, 17363973, 17568778, 17620599, 18266467, 18268325, 18579519, 18922877, 19666608, 198753 |
GO:0005524 |
Function |
ATP binding |
IEA |
|
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005737 |
Component |
Cytoplasm |
IBA |
21873635 |
GO:0005737 |
Component |
Cytoplasm |
IDA |
30341167 |
GO:0005829 |
Component |
Cytosol |
IDA |
|
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0006468 |
Process |
Protein phosphorylation |
IDA |
20434986 |
GO:0006954 |
Process |
Inflammatory response |
TAS |
18626576 |
GO:0006955 |
Process |
Immune response |
TAS |
9346484 |
GO:0007249 |
Process |
I-kappaB kinase/NF-kappaB signaling |
IMP |
26514923 |
GO:0007249 |
Process |
I-kappaB kinase/NF-kappaB signaling |
TAS |
18626576 |
GO:0007252 |
Process |
I-kappaB phosphorylation |
TAS |
9252186 |
GO:0007266 |
Process |
Rho protein signal transduction |
IEA |
|
GO:0008384 |
Function |
IkappaB kinase activity |
IBA |
21873635 |
GO:0008384 |
Function |
IkappaB kinase activity |
TAS |
18626576 |
GO:0008385 |
Component |
IkappaB kinase complex |
IBA |
21873635 |
GO:0008385 |
Component |
IkappaB kinase complex |
TAS |
18626576 |
GO:0009615 |
Process |
Response to virus |
TAS |
18626576 |
GO:0009636 |
Process |
Response to toxic substance |
IEA |
|
GO:0009653 |
Process |
Anatomical structure morphogenesis |
TAS |
10747982 |
GO:0009898 |
Component |
Cytoplasmic side of plasma membrane |
ISS |
|
GO:0010034 |
Process |
Response to acetate |
IEA |
|
GO:0010803 |
Process |
Regulation of tumor necrosis factor-mediated signaling pathway |
TAS |
|
GO:0018105 |
Process |
Peptidyl-serine phosphorylation |
IBA |
21873635 |
GO:0032088 |
Process |
Negative regulation of NF-kappaB transcription factor activity |
IMP |
11536016 |
GO:0032496 |
Process |
Response to lipopolysaccharide |
IEA |
|
GO:0032727 |
Process |
Positive regulation of interferon-alpha production |
IMP |
24784232 |
GO:0033194 |
Process |
Response to hydroperoxide |
IEA |
|
GO:0033209 |
Process |
Tumor necrosis factor-mediated signaling pathway |
IBA |
21873635 |
GO:0034614 |
Process |
Cellular response to reactive oxygen species |
IMP |
26514923 |
GO:0035631 |
Component |
CD40 receptor complex |
ISS |
|
GO:0035666 |
Process |
TRIF-dependent toll-like receptor signaling pathway |
TAS |
|
GO:0038061 |
Process |
NIK/NF-kappaB signaling |
IMP |
26514923 |
GO:0038061 |
Process |
NIK/NF-kappaB signaling |
TAS |
|
GO:0038095 |
Process |
Fc-epsilon receptor signaling pathway |
TAS |
|
GO:0042493 |
Process |
Response to drug |
IEA |
|
GO:0042803 |
Function |
Protein homodimerization activity |
IDA |
23091055 |
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IMP |
23487264 |
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
TAS |
|
GO:0043200 |
Process |
Response to amino acid |
IEA |
|
GO:0044877 |
Function |
Protein-containing complex binding |
IEA |
|
GO:0045087 |
Process |
Innate immune response |
TAS |
18626576 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IMP |
26514923 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IDA |
23091055 |
GO:0046982 |
Function |
Protein heterodimerization activity |
IDA |
23091055 |
GO:0050852 |
Process |
T cell receptor signaling pathway |
TAS |
|
GO:0051092 |
Process |
Positive regulation of NF-kappaB transcription factor activity |
IBA |
21873635 |
GO:0051092 |
Process |
Positive regulation of NF-kappaB transcription factor activity |
TAS |
18626576 |
GO:0051146 |
Process |
Striated muscle cell differentiation |
IEA |
|
GO:0051403 |
Process |
Stress-activated MAPK cascade |
TAS |
|
GO:0061847 |
Process |
Response to cholecystokinin |
IEA |
|
GO:0070498 |
Process |
Interleukin-1-mediated signaling pathway |
TAS |
|
GO:0071276 |
Process |
Cellular response to cadmium ion |
IMP |
26514923 |
GO:0071356 |
Process |
Cellular response to tumor necrosis factor |
IDA |
23091055 |
GO:0097110 |
Function |
Scaffold protein binding |
IDA |
23776175 |
GO:0098586 |
Process |
Cellular response to virus |
IMP |
24784232 |
GO:1990459 |
Function |
Transferrin receptor binding |
IPI |
23016877 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
O15111 |
Protein name |
Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) |
Protein function |
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities. Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP. Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:12789342, PubMed:15084260, PubMed:17434128, PubMed:20434986, PubMed:20501937, PubMed:21765415). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). |
PDB |
3BRT
,
5EBZ
,
5TQW
,
5TQX
,
5TQY
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00069 |
Pkinase |
15 → 298 |
Protein kinase domain |
Domain |
PF18397 |
IKBKB_SDD |
386 → 659 |
IQBAL scaffold dimerization domain |
Domain |
PF12179 |
IKKbetaNEMObind |
707 → 743 |
I-kappa-kinase-beta NEMO binding domain |
Domain |
|
Sequence |
|
Sequence length |
745 |
Interactions |
View interactions |